Products Categories
| CAS No.: | 53-16-7 |
|---|---|
| Name: | 1,3,5(10)-Estratrien-3-ol-17-one |
| Article Data: | 173 |
| Cas Database | |
| Molecular Structure: | |
|
|
|
| Formula: | C18H22O2 |
| Molecular Weight: | 270.371 |
| Synonyms: | delta-1,3,5-estratrien-3-beta-ol-17-one;Hormestrin;Oestrin;delta-1,3,5-oestratrien-3-beta-ol-17-one;Estrona [Spanish];CMC_13458;Ovifollin;Wynestron;component of Mal-O-Fem;Cristallovar;Menagen;Estrusol;hydroxyestrones;Ketohydroxyoestrin;.delta.-1,3, 5-Oestratrien-3.beta.-ol-17-one;Folipex;3-Hydroxy-17-keto-estra-1,3,5-triene;Disynformon;3-Hydroxy-oestra-1,3, 5(10)-trien-17-one;Estrone-A;Destrone;Ovex (tablets);Estrol;Follicunodis; |
| EINECS: | 200-164-5 |
| Density: | 1.164 g/cm3 |
| Melting Point: | 258-261 ºC |
| Boiling Point: | 445.2 ºC at 760 mmHg |
| Flash Point: | 189.7 ºC |
| Solubility: | water: 0.03 g/L |
| Appearance: | crystalline solid |
| Hazard Symbols: |
 T
|
| Risk Codes: | 45-60-61 |
| Safety: | 53-45 |
| PSA: | 37.30000 |
| LogP: | 3.81740 |
- 53167-11-6a-D-xylo-Pentodialdo-1,4-furanose,1,2-O-(1-methylethylidene)-
- 53170-19-7Dimethyl-d6-amine hydrochloride
- 53171-35-0Butanoic acid,4-amino-4-oxo-,ethyl ester
- 53171-39-4Butanoic acid,4-amino-4-oxo-, methyl ester
- 53172-74-02-Butenedioic acid(2Z)-, disodium salt, monohydrate (9CI)
- 53172-79-59H-Fluorene,9-bromo-2-nitro-
- 5317-32-81-Piperazinepropanol
- 5317-33-91-Piperazinepropanol,4-methyl-
- 53174-98-4Thieno[2,3-b]pyridine-2-carboxaldehyde
- 531-75-92H-1-Benzopyran-2-one,6-(b-D-glucopyranosyloxy)-7-hydroxy-
| Conditions | Yield |
|---|---|
| With Cp*Ir(6,6'-dionato-2,2'-bipyridine)(H2O) In tert-butyl alcohol at 130℃; for 20h; | 100% |
| With Cp*Ir(6,6'-dionato-2,2'-bipyridine)(H2O) In tert-butyl alcohol for 20h; Reflux; | 100% |
| With polystyrene-supported(cathecholato) oxoRe cat. act by iPrOH; dimethyl sulfoxide In toluene for 4h; Heating; Dean-Stark apparatus; | 98% |
| Conditions | Yield |
|---|---|
| 100% |
| Conditions | Yield |
|---|---|
| With methanol; zinc | 98% |
| With tetrabutyl ammonium fluoride In tetrahydrofuran at 27℃; for 72h; | 94% |
| With lipase from Candida cylindracea; octanol In various solvent(s) at 37℃; for 144h; | 90% |
| With sodium hydroxide In methanol; water for 0.25h; |
- 92803-51-5
17-oxo-1,3,5(10)-estratrien-3-yl 2-(trimethylsilyl)ethyl butanedioate
- 53-16-7
Estrone
| Conditions | Yield |
|---|---|
| With tetrabutyl ammonium fluoride In tetrahydrofuran at 27℃; for 24h; | 97% |
| Conditions | Yield |
|---|---|
| With toluene-4-sulfonic acid In diethyl ether Ambient temperature; | 96% |
| With toluene-4-sulfonic acid In diethyl ether Ambient temperature; Yield given; | |
| With acetic acid In chloroform-d1 |
- 1422954-71-9
C23H34O3Si
- 53-16-7
Estrone
| Conditions | Yield |
|---|---|
| With hydrogenchloride In tetrahydrofuran; water at 20℃; for 2h; | 95% |
| Conditions | Yield |
|---|---|
| With aluminium trichloride; sodium iodide In dichloromethane; acetonitrile for 5.5h; Heating; | 93% |
| Stage #1: estrone 3-methyl ether With aluminum (III) chloride; sodium iodide In dichloromethane at 0 - 20℃; Inert atmosphere; Stage #2: With hydrogenchloride; water In dichloromethane Inert atmosphere; | 92% |
| With boron tribromide at -30 - 0℃; for 2.5h; | 88% |
- 95282-98-7
19-acetoxyandrosta-1,4-diene-3,17-dione
- 53-16-7
Estrone
| Conditions | Yield |
|---|---|
| With sodium hydroxide In methanol at 20℃; for 0.05h; | 90% |
| With sodium hydroxide In methanol at 20℃; for 2h; | 76% |
| With potassium hydroxide In methanol at 20℃; for 2h; | 50.1% |
- 53-16-7
Estrone
| Conditions | Yield |
|---|---|
| With diethylamine In ethanol; dichloromethane at 55 - 60℃; for 8h; Hydrolysis; | 90% |
- 90850-47-8
3-<2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenoxy>estra-1,3,5(10)-trien-17-one
- 53-16-7
Estrone
| Conditions | Yield |
|---|---|
| With sodium methylate In N,N-dimethyl-formamide at 20℃; for 2h; Product distribution; regeneration reactions of the parent compound from different perfluoroaryl derivatives to the alcohols; other educts and products, different times, temperatures and mol ratios of the educts; | 87% |
What can I do for you?
Get Best Price
Chemistry
Molecular Structure of Estrone (CAS NO.53-16-7):
.png)
Molecular Formula: C18H22O2
Molecular Weight: 270.3661
IUPAC Name: (8R,9S,13S,14S)-3-Hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
CAS NO: 53-16-7
EINECS: 200-164-5
Classification Code: Drug / Therapeutic Agent ; Estrogen ; Estrogens ; Hormone ; Hormones ; Hormones, Hormone Substitutes, and Hormone Antagonists ; Human Data ; Mutation data ; Natural Product ; Reproductive Effect ; Tumor data
Melting point: 258-260 °C
Index of Refraction: 1.587
Molar Refractivity: 78.04 cm3
Molar Volume: 232.1 cm3
Surface Tension: 46 dyne/cm
Density: 1.164 g/cm3
Flash Point: 189.7 °C
Enthalpy of Vaporization: 73.02 kJ/mol
Boiling Point: 445.2 °C at 760 mmHg
Vapour Pressure: 1.54E-08 mmHg at 25 °C
alpha :158 °(c=1, dioxane)
refractive index: 165 °(C=1, Dioxane)
Water Solubility: 0.03 g/L
Product Categories: Steroids; Various Metabolites and Impurities; 17-Ketosteroids; Biochemistry; Hydroxyketosteroids; Metabolites & Impurities
Uses
Estrone (CAS NO.53-16-7) is mainly used as a metabolite of 17-Estradiol.
Consensus Reports
NTP 10th Report on Carcinogens. Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 6 , 1974,p. 123.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: )IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 21 , 1979,p. 343.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Reported in EPA TSCA Inventory.
Safety Profile
Hazard Codes of Estrone (CAS NO.53-16-7): 
T
Risk Statements: 45-60-61
R45: May cause cancer.
R60: May impair fertility.
R61: May cause harm to the unborn child.
Safety Statements: 53-45
S53: Avoid exposure - obtain special instructions before use.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
WGK Germany: 3
RTECS: KG8575000
Confirmed carcinogen with experimental carcinogenic, neoplastigenic, tumorigenic, and teratogenic data. A poison by intraperitoneal and subcutaneous routes. Human reproductive effects by implantation: spermatogenesis and impotence. Mutation data reported. A steroid drug for the treatment of menopause and ovariectomy symptoms. When heated to decomposition it emits acrid smoke and irritating fumes.
Specification
Synonyms of Estrone (CAS NO.53-16-7) are1,3,5(10)-Estratrien-3-ol-17-one ; 1,3,5(10)-Oestratrien-3-ol-17-one ; 3-08-00-01171 (Beilstein Handbook Reference) ; 3-Hydroxy-17-keto-estra-1,3,5-triene ; 3-Hydroxy-17-keto-oestra-1,3,5-triene ; 3-Hydroxy-oestra-1,3,5(10)-trien-17-one ; 3-Hydroxyestra-1,3,5(10)-trien-17-one ; 3-Hydroxyestra-1,3,5(10)-triene-17-one ; Aquacrine ; Crinovaryl ; Cristallovar ; Crystogen ; Destrone ; Disynformon ; E(sub 1) ; Endofolliculina ; Estra-1,3,5(10)-trien-17-one, 3-hydroxy- ; Estrogenic substance ; Estron ; Estrona ; Estrone-A ; Estronum ; Estrovarin ; Estrugenone ; Estrusol ; Fem-O-Gen ; Femestrone injection ; Femidyn ; Folikrin ; Folipex ; Folisan ; Follestrine ; Follestrol ; Follicular hormone ; Folliculin ; Folliculine ; Folliculine benzoate ; Follicunodis ; Glandubolin ; Hiestrone ; Hormestrin ; Hormofollin ; Hormovarine ; Kestrone ; Ketodestrin ; Ketohydroxy-estratriene ; Ketohydroxyestrin ; Ketohydroxyoestrin ; Kolpon ; Menagen ; Menformon ; Mestronaq ; Natural estrogenic substance-estrone ; Oestrin ; Oestroform ; Oestrone ; Oestronum ; Oestroperos ; Ovex (tablets) ; Ovifollin ; Perlatan ; Solliculin ; Theelin ; Thelestrin ; Thelykinin ; Thynestron ; Tokokin ; Unden ; Unden (pharmaceutical) ; Wynestron ; delta-1,3,5-Estratrien 3beta-ol-17-one ; delta-1,3,5-Oestratrien-3beta-ol-17-one ; delta-1,3,5-estratrien-3-beta-ol-17-one ; delta-1,3,5-oestratrien-3-beta-ol-17-one .